Anzeige
Mehr »
Freitag, 27.06.2025 - Börsentäglich über 12.000 News
Blockbuster-Bohrergebnisse: Gold-Antimon-Fund in Nevada trifft geopolitischen Nerv
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JNLV | ISIN: CA46604F1099 | Ticker-Symbol: 1R3
Stuttgart
27.06.25 | 08:00
0,129 Euro
+0,39 % +0,001
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
IZOTROPIC CORPORATION Chart 1 Jahr
5-Tage-Chart
IZOTROPIC CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
0,1190,15311:53
0,1280,14411:28

Aktuelle News zur IZOTROPIC Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
13.06.Izotropic Corp: Izotropic hires Evolux Capital for marketing services10
13.06.Izotropic Corporation: Izotropic Provides Marketing Update265Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - June 13, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device...
► Artikel lesen
10.06.Izotropic Corp: Izotropic, California university regents revise licence10
10.06.Izotropic Corporation: Izotropic Revises License Agreement with The Regents of the University of California159- License agreement enables U.S. FDA approval or foreign equivalent (CE mark) -- Amendment aligns with Company's timelines for IzoView product launch -- Agreement amendment fees of USD $85K payable...
► Artikel lesen
20.05.EQS-News: Izotropic Corporation: FDA-Zulassungsverfahren von Izotropic genehmigt - Unternehmen gibt Update625EQS-News: Izotropic Corporation / Schlagwort(e): Miscellaneous FDA-Zulassungsverfahren von Izotropic genehmigt - Unternehmen gibt Update 20.05.2025 / 21:48 CET/CEST Für...
► Artikel lesen
IZOTROPIC Aktie jetzt für 0€ handeln
17.05.Izotropic Corp: Izotropic in financing meetings for U.S. clinical study6
17.05.Izotropic Corporation: Izotropic's U.S. FDA Regulatory Pathway Greenlit, Company Provides Corporate Update1.065- Regulatory alignment with FDA confirmed, clearing path to pivotal U.S. clinical trial -- 150-page strategic business plan and advanced financial models completed -- Investor outreach launched to...
► Artikel lesen
03.04.Izotropic Corp: Izotropic hires international communications consultant5
02.04.Izotropic Corporation: Izotropic Engages International Communications Consultant, Grants Incentive Stock Options & RSUs to Key Personnel, Amends Promissory Note with Primary Lender578Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - April 2, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device...
► Artikel lesen
25.03.Izotropic Corp: Izotropic completes presubmission meeting with FDA4
25.03.Izotropic Corporation: Izotropic Completes Pre-Submission Meeting with FDA for Breast Cancer Screening Indication221- FDA meeting facilitated positive collaborative exchange -- Key topics included the clinical study protocol synopsis, the benefits versus risks of contrast-enhancement, and the management of breast...
► Artikel lesen
10.03.Izotropic Corporation: Izotropic to Present at Investor Conference March 13th288- CEO to discuss IzoView's competitive advantage, expansion strategy, and potential revenue models -- Event includes live Q and A, attendance is complimentary -- Individual and institutional investors...
► Artikel lesen
19.02.Izotropic Corp: Izotropic to meet with U.S. FDA on March 2019
19.02.Izotropic Corporation: FDA Sets Meeting Date with Izotropic248Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - February 19, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device...
► Artikel lesen
14.02.Izotropic Corp: Izotropic closes $455,000 private placement2
14.02.Izotropic Corporation: Izotropic Closes Non-Brokered Private Placement306Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - February 14, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device...
► Artikel lesen
07.02.Izotropic Corp: Izotropic arranges $360,000 private placement2
07.02.Izotropic Corporation: Izotropic Announces Non-Brokered Private Placement433THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia and Sacramento, California--(Newsfile Corp. - February 7, 2025)...
► Artikel lesen
06.02.Izotropic Corp: Izotropic CEO cancels OTC conference over emergency9
06.02.Izotropic Corporation: Izotropic Reschedules Investor Conference Presentation to March 13th624Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - February 5, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device...
► Artikel lesen
Weiter >>
31 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2